Back
Product details:
CAS
319460-85-0
Purity
95%
Axitinib is an oral VEGFR and kinase inhibitor used for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy.
Properties
Name
Axitinib
Smiles
CNC(=O)C=1C=CC=CC1SC=2C=CC=3C(/C=C/C=4C=CC=CN4)=NNC3C2
Targets
Please log in to see this information
Sold for research purposes under agreement from Pfizer Inc.
Axitinib is a targeted research compound widely recognized in oncology and angiogenesis studies as an axitinib small molecule and an axitinib small molecule tyrosine kinase inhibitor. Originally developed as axitinib Pfizer, it is associated with well-documented activity against vascular endothelial growth factor receptor pathways and is frequently referenced by scientists who compare supplier data, published assays, and Pfizer axitinib details before selecting a material for screening or validation work. For catalog-oriented searches, researchers often review axitinib chemical structure, axitinib structure, axitinib smiles, axitinib molecular formula, and axitinib molecular weight together with the identifier axitinib CAS number 319460-85-0 or simply 319460-85-0.
In regulated and reference-oriented documentation, Pfizer axitinib unii is commonly searched alongside product identifiers. The compound is listed with molecular formula C22H18N4OS and a molecular weight of 386.47, which makes these descriptors useful when confirming identity, comparing analytical files, or aligning procurement records across discovery teams.
Axitinib is used in research settings focused on receptor tyrosine kinase signaling, tumor angiogenesis, and compound-response profiling. Scientists working in early drug discovery often evaluate Pfizer axitinib or Pfizer axitinib chemical structure when building kinase-focused panels, benchmarking VEGFR-directed compounds, or selecting a reference molecule for assay controls. Because of its recognized profile and traceable literature history, axitinib remains relevant for mechanism-driven workflows in cancer biology, translational pharmacology, and kinase inhibitor comparison studies.
In vitro, axitinib is frequently applied in biochemical and cell-based models designed to assess VEGFR pathway inhibition, downstream phosphorylation changes, and proliferation effects in responsive systems. Its profile is particularly valuable when a study requires a defined inhibitor with literature-backed potency across VEGFR-related targets. When researchers search buy axitinib for laboratory use, they often need more than availability - they also need clean structural data, reliable identifiers, and product-level transparency that supports rapid qualification for assay setup.
In vivo research interest in axitinib is linked to angiogenesis modulation, tumor vascular biology, and dose-response studies in preclinical oncology models. As with many reference compounds originating from clinically relevant programs, demand is often driven by teams that want continuity between published data and procurement criteria. This is why search patterns such as buy axitinib online, axitinib CAS no, and Pfizer axitinib appear together - buyers are usually verifying the same compound across multiple databases, suppliers, and internal documentation systems before ordering.
The main biochemical role of axitinib is inhibition of receptor tyrosine kinase signaling associated with angiogenic regulation. In practical research terms, that means it is used to study how VEGFR-centered pathways influence endothelial behavior, tumor microenvironment signaling, and pharmacological response. Its established identity as an axitinib small molecule supports use in pathway mapping, comparative inhibitor studies, and validation of target-specific hypotheses where compound traceability matters as much as biological relevance.
For research teams selecting EBC-219024, the value of this compound lies not only in the molecule itself but also in the quality of the supporting product environment described in the Enamine content brief: strong search convenience, broad access to bioactive compounds, and scientific support tailored to discovery workflows. These factors are especially important when scientists need fast confirmation of structure, identifiers, and sourcing before moving from shortlist to purchase.
For teams that need a well-characterized VEGFR-focused research molecule with recognizable literature background, EBC-219024 offers a practical route to buy axitinib with the technical clarity expected in modern discovery programs.
SDS
(E)-axitinib | AG-013736 | Inlyta | axitinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$53
2 mg
$54
5 mg
$55
10 mg
$66
15 mg
$73
20 mg
$81
25 mg
$90
30 mg
$100
35 mg
$108
40 mg
$116
45 mg
$122
50 mg
$136
75 mg
$208
100 mg
$238
Quantity
1
Total amount
$ 55
(E)-axitinib | AG-013736 | Inlyta | axitinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.